In summary, our results revealed that FIBP may promote CRC cell proliferation and stemness via inhibition of the GSK3β-mediated β-catenin/cyclin D1 pathway and methylation of stemness genes (Figure S9). This evidence concerns the gene CCND1 and colorectal carcinoma.